A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality.

Authors

Margaret L. MacMillan
Marie Robin
Andrew C. Harris
Todd E. DeFor
Paul J. MartinFollow
Amin Alousi
David Jacobsohn, George Washington UniversityFollow
+12 additional authors

Document Type

Journal Article

Publication Date

4-2015

Journal

Biology of Blood and Bone Marrow Transplantation

Volume

21

Issue

4

Inclusive Pages

761-767

DOI

10.1016/j.bbmt.2015.01.001

Keywords

Graft vs Host Disease--mortality; Hematologic Neoplasms--mortality; Hematologic Neoplasms--therapy

APA Citation

MacMillan, M.L., Robin, M., Harris, A.C., Defor, T.E., Martin, P.J., Alousi, A.,...Weisdorf, D.J. (2015). A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biology of Blood and Marrow Transplantation, 761-767. doi: 10.1016/j.bbmt.2015.01.001

Peer Reviewed

1